Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.305
+0.055 (1.29%)
Jun 10, 2026, 10:14 AM EDT - Market open
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $47.4 million as of June 10, 2026. Its market cap has increased by 49.35% in one year.
Market Cap
47.40M
Enterprise Value
21.81M
1-Year Change
49.35%
Ranking
Category
Stock Price
$4.31
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $47.40M, a decrease of -34.94%. That is a compound annual growth rate of -9.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 47.40M | -19.81% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veru Inc. | 49.11M |
| Edesa Biotech | 48.09M |
| Mereo BioPharma Group | 48.04M |
| Immutep | 47.71M |
| Dogwood Therapeutics | 47.35M |
| Estrella Immunopharma | 47.34M |
| Metagenomi Therapeutics | 47.06M |
| Actuate Therapeutics | 46.21M |